Latest Headlines

• 

  3 Healthcare Stock Stories For Weekend Investment Wellness

  Mark Lawson   | Fri, Apr 19 |  Comment
• 

  Pluristem Wants Bloomberg Retraction, Array Sets Secondary: Healthcare Biz Wrap

  Mark Lawson   | Sat, Nov 10 |  Comment
• 

  Here are 5 Biopharmaceutical Companies on the Rise

  Meghan Foley   | Mon, Oct 15 |  Comment
• 

  Healthcare Business Recap: Apricus LICENSES Takeda, Cornerstone's Med Rejected By FDA

  Mark Lawson   | Fri, Sep 14 |  Comment
• 

  Healthcare Biz Recap: Pluristem Shares SURGE, Amarin Gets New PATENTS

  Mark Lawson   | Thu, Sep 6 |  Comment
• 

  Healthcare Business Review: St Jude's Defibrillator FAILS Test, Allergan's PARTNERSHIP

  Mark Lawson   | Wed, Aug 22 |  Comment
• 

  Healthcare Biz Recap: Vivus' PATENT Problem, Idenix Survives Clinical HOLD

  Mark Lawson   | Sat, Aug 18 |  Comment
• 

  Palo Alto Networks Gets BOOST from Cisco Success and 4 Stocks Hitting 52-Week Highs

  Leah Powell   | Fri, Aug 17 |  Comment
• 

  Novartis ANNOUNCES Research Collaboration with UPenn and 4 Stocks Reaching 52-Week Highs

  Mark Lawson   | Tue, Aug 7 |  Comment
• 

  Healthcare Business Recap: Teva Gets SEC SUBPOENA, 3 Other Stocks POP

  Mark Lawson   | Tue, Aug 7 |  Comment
• 

  Pluristem Therapeutics INITIATED at Buy and 3 Analyst-Initiated Shares to Note

  Jose Fajardo   | Wed, Jul 25 |  Comment
• 

  RadioShack SLIDES to Sell and 4 Anayst-Downgraded Shares

  Emily Jones   | Tue, Jul 24 |  Comment